|Dr. Michael P. Monsour F.A.C.I.D., FACRRM, FAICD, M.D., MBBS, MBBS-HONS||Exec. Chairman||82.5k||N/A||N/A|
|Mr. Geoff Daly BE (Hons, Mech, UQ), MBA (Exec, AGSM), MIEAust CPE||Chief Exec. Officer||325.88k||N/A||N/A|
|Mr. Ross Mangelsdorf B.Bus, CTA, F.C.A., FCA, FTIA, M.A.I.C.D., MAICD||CFO & Non-Exec. Director||193.6k||N/A||N/A|
|Ms. Chelsea Cornelius||Chief Operating Officer||N/A||N/A||N/A|
|Ms. Megan Henken||VP of Global Marketing||N/A||N/A||N/A|
|Mr. Bryan Dulhunty ACA, BEc, C.A.||Company Sec.||N/A||N/A||N/A|
Analytica Limited designs, develops, and supplies medical devices in Australia, China, and the Middle East. The company's lead product includes PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Autostart Burette Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited was incorporated in 1985 and is based in Brisbane, Australia.
Analytica Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.